Posts

Showing posts from August, 2023

Things You Should Know About Custom Active Pharmaceutical Ingredients

Image
  Nonetheless, despite the formidable manufacturing costs, stringent regulatory requirements, and policies aimed at controlling pharmaceutical prices in various countries, the API market has seen promising opportunities arise. This can be attributed to the increasing prevalence of chronic diseases like diabetes, asthma, and cancer within the population. In the pharmaceutical realm, an Active Pharmaceutical Ingredient (API) is defined as any constituent that exhibits pharmacological activity or has direct effects in diagnosing, curing, mitigating, treating, or preventing diseases, or that influences the structure of the human or animal body. Custom Active Pharmaceutical Ingredients (APIs) are the pharmaceutical compounds specifically designed to produce the desired effects on the body to address a particular medical condition. These APIs are developed through the processing of chemical molecules. In the pharmaceutical industry, an API in a biologic medication serves as a pivotal in...

Mitigating Risk with Robust Quality Assurance Practices in Pharmaceutical Fill Finish

Image
  As the saying goes, "an ounce of prevention is worth a pound of cure." In the world of pharmaceutical fill finish, this couldn't be truer. The importance of robust quality assurance practices cannot be overstated. With patient safety at stake, it's essential to have robust practices in place for mitigating risk and ensuring product efficacy. This is where fill finish processes come into play - the final stage in drug manufacturing before packaging and distribution. In this blog post, we'll explore the key elements of a comprehensive quality assurance program and how they can help minimize risks throughout the fill finish process.   Keys to Quality Assurance in Pharmaceutical Fill Finish The pharmaceutical industry is under constant pressure to improve product quality while minimizing cost and maximizing efficiency. Therefore, in order to ensure quality and minimize risk, it is essential to have robust quality assurance practices in place throughout the drug fill...

Maximizing Efficiency with Hot Melt Extrusion Technology

Image
  Are you tired of grappling with inefficient and time-consuming manufacturing processes? Are you eager to boost productivity while minimizing waste in your production line? Look no further than the transformative power of Hot Melt Extrusion (HME) technology. From pharmaceuticals to plastics, HME has ushered in a new era of product manufacturing. In this blog post, we'll delve into the compelling advantages of incorporating HME technology into your manufacturing processes and explore how it can revolutionize your operations. Get ready to streamline your production and elevate your business to new heights with HME! Introduction to Hot Melt Extrusion (HME) Technology Hot Melt Extrusion (HME) is a cutting-edge process employed in the creation of products from thermoplastic materials. It entails melting the material and then extruding it through a die or nozzle to attain the desired shape. HME boasts incredible versatility, finding applications in the manufacturing of medical devices,...

Leading the Way in Potent Drug Contract Manufacturing

Image
  Did you know that only about one-third of drug production is carried out in-house? Furthermore, the United States' limited focus on STEM education has resulted in a shortage of skilled professionals in the pharmaceutical industry. The process of drug manufacturing is incredibly intricate, spanning from research and development to commercial production. Meeting the ever-growing demand for pharmaceuticals has placed a substantial financial burden on drug contract manufacturing companies, particularly when it comes to acquiring and operating expensive production equipment. In response to these challenges, many corporations have begun outsourcing their manufacturing needs to drug contract manufacturing firms, which possess the necessary equipment, facilities, and skilled workforce to produce drugs at a lower cost. The industry has witnessed remarkable growth, with contract manufacturing expanding from $934.8 billion in 2017 to a staggering $1.17 trillion in 2021. Clearly, potent drug...